In H115, Circle Holdings (Circle) achieved revenue growth of 28% y-o-y so that EBITDA losses fell to 6.4% of revenue from 12% the year before. Circle does not feel it is under the same pressure on NHS work as its competitor Spire, because it relies less on block bookings for NHS contracts and more on individual choice. The result of the UK general election has reduced some of the political uncertainty that had affected the company and the UK health economy and it is actively bidding for new contracts. Circle has funding in place, in principle, to build a new hospital in Birmingham and planning approval was achieved in September. It has also just announced a joint venture to create an innovative proton beam treatment centre.
